Team:EPF-Lausanne/Our Project/TetR mutants

From 2011.igem.org

(Difference between revisions)
 
(18 intermediate revisions not shown)
Line 1: Line 1:
-
{{:Team:EPF-Lausanne/Templates/Header|title=TetR mutants}}
+
{{:Team:EPF-Lausanne/Templates/TetRtemplate|title=''In-Vitro'' Characterization}}
-
to write here: how we got TetR mutants, with which method (we can also explain the method in the "tools" section)
+
When we generate new libraries of transcription factors using site-directed mutagenesis, we need to have a precise and high-throughput characterization method. These two requirements are met by the microfluidics MITOMI device that we used.
-
The MITOMI characterization will be explained in the "tool" section?
+
 
 +
Characterizing a lot of different mutants will allow us to get a better understanding of the mutations influencing the specificity and affinity of a transcription factor. With these parameters in hand, we will be able to fine-tune the characteristics of the newly produced transcription factors.
 +
 
 +
The new transcription factors mutants characterized in vitro then need to be tested ''in vivo''. This last step is explained in the " ''in vivo'' characterization section".
 +
 
 +
[[File:EPFL-Solange-MITOMI.jpg|700px]]
{{:Team:EPF-Lausanne/Templates/Footer}}
{{:Team:EPF-Lausanne/Templates/Footer}}

Latest revision as of 02:59, 22 September 2011